THE EMERGING BIOTECH LEADER

LIVE

Serial Number

98709935

Owner

SSI Strategy LLC

Attorney

Jason H. Kasner

First Use Date

Sep 5, 2022

Filing Date

Aug 21, 2024

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

THE EMERGING BIOTECH LEADER Trademark

Serial Number: 98709935 • Registration: 8053979

THE EMERGING BIOTECH LEADER is a trademark filed by SSI Strategy LLC on August 21, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment). The application is currently registered and active.

Trademark Classes

Class 9 - Computers & Electronics

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Class 41 - Education & Entertainment

Education; providing of training; entertainment; sporting and cultural activities

Owner Contact Info

SSI Strategy LLC (9 trademarks)

9 Campus Drive, Suite 103
Parsippany, NJ 07054

Entity Type: 16

Legal Representation

Attorney of Record

Jason H. Kasner

359 trademarks filed View all →

Correspondence Address

Jason H. Kasner Lerner David LLP

20 Commerce Drive

Cranford, NJ 07016

United States

Trademark Details

Filing Date

August 21, 2024

Registration Date

December 2, 2025

First Use Anywhere

September 5, 2022

First Use in Commerce

September 5, 2022

Goods & Services

Educational and entertainment services, namely, providing podcasts in the field of pharmaceuticals, biotechnology and life sciences

Downloadable podcasts in the field of pharmaceuticals, biotechnology and life sciences

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Dec 2, 2025 NRCS

REGISTERED-SUPPLEMENTAL REGISTER

Dec 2, 2025 R.SR

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

Oct 30, 2025 CNTA

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 20, 2025 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 20, 2025 CRFA

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Oct 20, 2025 ERFR

NOTIFICATION OF FINAL REFUSAL EMAILED

Aug 11, 2025 GNFN

FINAL REFUSAL E-MAILED

Aug 11, 2025 GNFR

FINAL REFUSAL WRITTEN

Aug 11, 2025 CNFR

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 6, 2025 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 6, 2025 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 6, 2025 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 6, 2025 GNRN

NON-FINAL ACTION E-MAILED

Mar 6, 2025 GNRT

NON-FINAL ACTION WRITTEN

Mar 6, 2025 CNRT

ASSIGNED TO EXAMINER

Feb 26, 2025 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 21, 2024 NWOS

NEW APPLICATION ENTERED

Aug 21, 2024 NWAP

Related Trademarks

More from this Owner

PHARM APPROVE PREPARE TO WIN

SSI STRATEGY

BUILDING BETTER BIOTECHS

More in Same Class

LYNWELL L